Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Akt
    (5)
  • FOXO
    (4)
  • FOXO1
    (4)
  • 5-HT Receptor
    (2)
  • Apoptosis
    (2)
  • Autophagy
    (2)
  • TNF
    (2)
  • AMPK
    (1)
  • FOXO3
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

foxo1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    16
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    5
    TargetMol | Natural_Products
  • Recombinant Protein
    5
    TargetMol | Recombinant_Protein
  • Antibody Products
    14
    TargetMol | Antibody_Products
Kihadanin B
TN439073793-68-7
Kihadanin B can repress the adipogenesis by decreasing lipid accumulation through the suppression of the Akt-FOXO1-PPARγ axis in 3T3-L1 adipocytes.
  • $2,340
Inquiry
Size
QTY
Oxypaeoniflorin
Oxypaeoniflora
T377339011-91-1
Oxypaeoniflorin a monoterpene glycoside compound isolated from Paeoniae, is an antioxidant, is neuroprotective and anti-inflammatory.
  • $50
In Stock
Size
QTY
Marein
TN1911535-96-6
Marein shows neuroprotective effect on PC12 cell damage induced by methylglyoxal, which is due to a reduction of damage to mitochondria function and activation of the AMPK signal pathway, it may be a potent compound for preventing/counteracting diabetic e
  • $33
In Stock
Size
QTY
Hymenidin
T27564107019-95-4In house
Hymenidin, an alkaloid isolated from the Okinawan sponge Hymeniacidon sp. is a 5-hydroxytryptaminergic receptor antagonist and voltage-gated potassium channel inhibitor with potential antiprotozoal effects.It selectively binds to FOXO1 DNA and reduces depolarization-induced elevation of cellular calcium.
  • $2,420
10-14 weeks
Size
QTY
Kushenol I
TN184299119-69-4
Kushenol I is a bioactive compound exhibiting anti-inflammatory, antioxidant, and ulcerative colitis–ameliorating effects, demonstrated in a DSS-induced UC mouse model where oral administration improved colon length, body weight, and disease scores while reducing pro-inflammatory cytokines including IL-1β, IL-6, IL-17, and TNF-α. Kushenol I increase IL-10 expression, inhibited key inflammatory signaling proteins such as AKT, p38 MAPK, PI3K, NLRP3, FOXO1, and TLR4, enhancing intestinal barrier integrity. Kushenol I positively modulate gut microbiota, and elevated splenic T-cell proportions, supporting therapeutic potential in inflammatory bowel disease.
  • $117
In Stock
Size
QTY